Analyst firms · Citigroup · ILMN
Citigroup ILMN price target and rating history
Illumina Inc. (ILMN) · Health Care
Citigroup rates Illumina Inc. (ILMN) Neutral with a $90 price target, as of its latest action on Mar 4, 2025. It has published 5 rating actions on ILMN since December 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
- Current rating
- Neutral
- Price target
- $90
- Median target, all firms
- $185
- Actions on ILMN
- 5
Citigroup price target on ILMN
Every Citigroup rating on ILMN
- Mar 4, 2025
- Dec 11, 2024
- Jul 10, 2024
- Dec 11, 2023
- Dec 12, 2022
How other firms rate ILMN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stephens | Equal-Weight | $275 | Oct 23, 2026 |
| UBS | Buy | $260 | Sep 9, 2026 |
| Bernstein | Mkt Perform | $185 | Jun 26, 2026 |
| RBC Capital Markets | Outperform | $170 | May 15, 2026 |
| Daiwa | Outperform | $155 | May 14, 2026 |
Questions about Citigroup and ILMN
- What is Citigroup's price target for ILMN?
- Citigroup's latest stated price target for Illumina Inc. (ILMN) is $90, from its action on Mar 4, 2025.
- What is Citigroup's rating on ILMN?
- Citigroup rates ILMN Neutral, a neutral rating, as of Mar 4, 2025.
- When did Citigroup last change its view on ILMN?
- On Mar 4, 2025, Citigroup cuts its price target to $90 from $130, keeps Neutral.
- How does Citigroup's ILMN target compare with other analysts?
- Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
More ILMN rating histories
All Citigroup ratingsILMN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.